Benzinga | Apr 27, 2021 04:19PM EDT

CRISPR Therapeutics Q1 EPS $(1.51) Down From $(1.15) YoY, Sales $539.00K Up From $157.00K YoY

CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly losses of $(1.51) per share. This is a 31.3 percent decrease over losses of $(1.15) per share from the same period last year. The company reported $539.00 thousand in sales this quarter. This is a 243.31 percent increase over sales of $157.00 thousand the same period last year.